Login / Signup

Severe non-atopic asthma: omalizumab can reduce severe asthma exacerbations.

Lise MelscoetNaji KhayathNicolas MigueresMarc-André GoltzeneNicolas MeyerFréderic de Blay
Published in: The Journal of asthma : official journal of the Association for the Care of Asthma (2022)
Omalizumab was effective in severe asthma, regardless of atopic status.
Keyphrases
  • chronic obstructive pulmonary disease
  • atopic dermatitis
  • lung function
  • cystic fibrosis
  • early onset
  • allergic rhinitis
  • drug induced